News

Teva Pharmaceutical Industries and Royalty Pharma have signed a funding agreement valued at up to $500 million to advance the development of TEV-408, an investigational therapy for autoimmune disorders, including vitiligo. The Teva, Royalty Pharma $500M deal would be...

An integrated partnership has been formed between Pierre Fabre Laboratories and Iktos to advance AI-driven oncology drug discovery. The collaboration focuses on identifying and developing new small-molecule drug candidates by combining Iktos’ AI and robotics technologies with Pierre Fabre’s...

Revvity, Inc. announced a collaboration with Eli Lilly and Company to broaden access to Lilly TuneLab by bringing the platform to the Revvity Signals ecosystem. The collaboration builds on Revvity’s recently launched Signals Xynthetica offering and aims to accelerate...

Have you ever felt like you’re constantly tired, even after a full night’s sleep? Like your mind is always racing, your shoulders are always tense, and peace feels more like a rumor than a reality? If so, you’re not...

If you have ever felt pulled toward a career where you help people through real challenges, social work may be on your mind. Many people feel interested in this field, but still pause before committing. That hesitation makes sense....

Amgen is going ahead and adding Dark Blue to its tapestry, embedding the preclinical blood cancer program of U.K. biotech into its organization. The California pharma has gone ahead and stitched together a deal of almost $840 million for Dark Blue Therapeutics, which is...

Daiichi Sankyo is now looking out for new horizons when it comes to its leukemia med Vanflyta, with Genesis Pharma signing to commercialize the drug across certain European countries. This exclusive license, as well as the supply agreement goes on to...